An artificial heart is a device that replaces the heart. Artificial hearts are typically used to bridge the time to heart transplantation, or to permanently replace the heart in case heart transplantation is impossible. A ventricular assist device (VAD) 鈥� also known as a mechanical circulatory support device 鈥� is an implantable mechanical pump that helps pump blood from the lower chambers of your heart (the ventricles) to the rest of your body. A VAD is used in people who have weakened hearts or heart failure.
The global Artificial Heart and Ventricular Assist Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Artificial Heart and Ventricular Assist Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Heart and Ventricular Assist Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Artificial Heart and Ventricular Assist Devices include SynCardia Systems, Medtronic PLC, Abbott Laboratories, BiVACOR, Berlin Heart, ABIOMED, LivaNova PLC, CARMAT and Jarvik Heart Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Artificial Heart and Ventricular Assist Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Heart and Ventricular Assist Devices.
Report Scope
The Artificial Heart and Ventricular Assist Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Heart and Ventricular Assist Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Heart and Ventricular Assist Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
SynCardia Systems
Medtronic PLC
Abbott Laboratories
BiVACOR
Berlin Heart
ABIOMED
LivaNova PLC
CARMAT
Jarvik Heart Inc
Chongqing Yongrenxin Medical
Thoratec
Cleveland Heart
CryoLife
Segment by Type
Artificial Heart
Ventricular Assist Devices
Segment by Application
Coronary Heart Disease
Cerebrovascular Disease
Peripheral Arterial Disease
Rheumatic Heart Disease
Congenital Heart Disease
Deep Vein Thrombosis
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Heart and Ventricular Assist Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Heart and Ventricular Assist Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Artificial Heart and Ventricular Assist Devices 麻豆原创 Overview
1.1 Product Overview and Scope of Artificial Heart and Ventricular Assist Devices
1.2 Artificial Heart and Ventricular Assist Devices Segment by Type
1.2.1 Global Artificial Heart and Ventricular Assist Devices 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Artificial Heart
1.2.3 Ventricular Assist Devices
1.3 Artificial Heart and Ventricular Assist Devices Segment by Application
1.3.1 Global Artificial Heart and Ventricular Assist Devices 麻豆原创 Value by Application: (2024-2030)
1.3.2 Coronary Heart Disease
1.3.3 Cerebrovascular Disease
1.3.4 Peripheral Arterial Disease
1.3.5 Rheumatic Heart Disease
1.3.6 Congenital Heart Disease
1.3.7 Deep Vein Thrombosis
1.3.8 Other
1.4 Global Artificial Heart and Ventricular Assist Devices 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Artificial Heart and Ventricular Assist Devices Revenue 2019-2030
1.4.2 Global Artificial Heart and Ventricular Assist Devices Sales 2019-2030
1.4.3 Global Artificial Heart and Ventricular Assist Devices 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Artificial Heart and Ventricular Assist Devices 麻豆原创 Competition by Manufacturers
2.1 Global Artificial Heart and Ventricular Assist Devices Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Artificial Heart and Ventricular Assist Devices Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Artificial Heart and Ventricular Assist Devices Average Price by Manufacturers (2019-2024)
2.4 Global Artificial Heart and Ventricular Assist Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artificial Heart and Ventricular Assist Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artificial Heart and Ventricular Assist Devices, Product Type & Application
2.7 Artificial Heart and Ventricular Assist Devices 麻豆原创 Competitive Situation and Trends
2.7.1 Artificial Heart and Ventricular Assist Devices 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Artificial Heart and Ventricular Assist Devices Players 麻豆原创 Share by Revenue
2.7.3 Global Artificial Heart and Ventricular Assist Devices 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Heart and Ventricular Assist Devices Retrospective 麻豆原创 Scenario by Region
3.1 Global Artificial Heart and Ventricular Assist Devices 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Artificial Heart and Ventricular Assist Devices Global Artificial Heart and Ventricular Assist Devices Sales by Region: 2019-2030
3.2.1 Global Artificial Heart and Ventricular Assist Devices Sales by Region: 2019-2024
3.2.2 Global Artificial Heart and Ventricular Assist Devices Sales by Region: 2025-2030
3.3 Global Artificial Heart and Ventricular Assist Devices Global Artificial Heart and Ventricular Assist Devices Revenue by Region: 2019-2030
3.3.1 Global Artificial Heart and Ventricular Assist Devices Revenue by Region: 2019-2024
3.3.2 Global Artificial Heart and Ventricular Assist Devices Revenue by Region: 2025-2030
3.4 North America Artificial Heart and Ventricular Assist Devices 麻豆原创 Facts & Figures by Country
3.4.1 North America Artificial Heart and Ventricular Assist Devices 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2030)
3.4.3 North America Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Artificial Heart and Ventricular Assist Devices 麻豆原创 Facts & Figures by Country
3.5.1 Europe Artificial Heart and Ventricular Assist Devices 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2030)
3.5.3 Europe Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Heart and Ventricular Assist Devices 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Artificial Heart and Ventricular Assist Devices 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Artificial Heart and Ventricular Assist Devices 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Artificial Heart and Ventricular Assist Devices 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2030)
3.7.3 Latin America Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Heart and Ventricular Assist Devices 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Heart and Ventricular Assist Devices 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Artificial Heart and Ventricular Assist Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Artificial Heart and Ventricular Assist Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Artificial Heart and Ventricular Assist Devices Sales by Type (2019-2030)
4.1.1 Global Artificial Heart and Ventricular Assist Devices Sales by Type (2019-2024)
4.1.2 Global Artificial Heart and Ventricular Assist Devices Sales by Type (2025-2030)
4.1.3 Global Artificial Heart and Ventricular Assist Devices Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Artificial Heart and Ventricular Assist Devices Revenue by Type (2019-2030)
4.2.1 Global Artificial Heart and Ventricular Assist Devices Revenue by Type (2019-2024)
4.2.2 Global Artificial Heart and Ventricular Assist Devices Revenue by Type (2025-2030)
4.2.3 Global Artificial Heart and Ventricular Assist Devices Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Artificial Heart and Ventricular Assist Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Artificial Heart and Ventricular Assist Devices Sales by Application (2019-2030)
5.1.1 Global Artificial Heart and Ventricular Assist Devices Sales by Application (2019-2024)
5.1.2 Global Artificial Heart and Ventricular Assist Devices Sales by Application (2025-2030)
5.1.3 Global Artificial Heart and Ventricular Assist Devices Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Artificial Heart and Ventricular Assist Devices Revenue by Application (2019-2030)
5.2.1 Global Artificial Heart and Ventricular Assist Devices Revenue by Application (2019-2024)
5.2.2 Global Artificial Heart and Ventricular Assist Devices Revenue by Application (2025-2030)
5.2.3 Global Artificial Heart and Ventricular Assist Devices Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Artificial Heart and Ventricular Assist Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 SynCardia Systems
6.1.1 SynCardia Systems Corporation Information
6.1.2 SynCardia Systems Description and Business Overview
6.1.3 SynCardia Systems Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 SynCardia Systems Artificial Heart and Ventricular Assist Devices Product Portfolio
6.1.5 SynCardia Systems Recent Developments/Updates
6.2 Medtronic PLC
6.2.1 Medtronic PLC Corporation Information
6.2.2 Medtronic PLC Description and Business Overview
6.2.3 Medtronic PLC Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic PLC Artificial Heart and Ventricular Assist Devices Product Portfolio
6.2.5 Medtronic PLC Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Laboratories Artificial Heart and Ventricular Assist Devices Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 BiVACOR
6.4.1 BiVACOR Corporation Information
6.4.2 BiVACOR Description and Business Overview
6.4.3 BiVACOR Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BiVACOR Artificial Heart and Ventricular Assist Devices Product Portfolio
6.4.5 BiVACOR Recent Developments/Updates
6.5 Berlin Heart
6.5.1 Berlin Heart Corporation Information
6.5.2 Berlin Heart Description and Business Overview
6.5.3 Berlin Heart Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Berlin Heart Artificial Heart and Ventricular Assist Devices Product Portfolio
6.5.5 Berlin Heart Recent Developments/Updates
6.6 ABIOMED
6.6.1 ABIOMED Corporation Information
6.6.2 ABIOMED Description and Business Overview
6.6.3 ABIOMED Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ABIOMED Artificial Heart and Ventricular Assist Devices Product Portfolio
6.6.5 ABIOMED Recent Developments/Updates
6.7 LivaNova PLC
6.6.1 LivaNova PLC Corporation Information
6.6.2 LivaNova PLC Description and Business Overview
6.6.3 LivaNova PLC Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LivaNova PLC Artificial Heart and Ventricular Assist Devices Product Portfolio
6.7.5 LivaNova PLC Recent Developments/Updates
6.8 CARMAT
6.8.1 CARMAT Corporation Information
6.8.2 CARMAT Description and Business Overview
6.8.3 CARMAT Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CARMAT Artificial Heart and Ventricular Assist Devices Product Portfolio
6.8.5 CARMAT Recent Developments/Updates
6.9 Jarvik Heart Inc
6.9.1 Jarvik Heart Inc Corporation Information
6.9.2 Jarvik Heart Inc Description and Business Overview
6.9.3 Jarvik Heart Inc Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jarvik Heart Inc Artificial Heart and Ventricular Assist Devices Product Portfolio
6.9.5 Jarvik Heart Inc Recent Developments/Updates
6.10 Chongqing Yongrenxin Medical
6.10.1 Chongqing Yongrenxin Medical Corporation Information
6.10.2 Chongqing Yongrenxin Medical Description and Business Overview
6.10.3 Chongqing Yongrenxin Medical Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Chongqing Yongrenxin Medical Artificial Heart and Ventricular Assist Devices Product Portfolio
6.10.5 Chongqing Yongrenxin Medical Recent Developments/Updates
6.11 Thoratec
6.11.1 Thoratec Corporation Information
6.11.2 Thoratec Artificial Heart and Ventricular Assist Devices Description and Business Overview
6.11.3 Thoratec Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Thoratec Artificial Heart and Ventricular Assist Devices Product Portfolio
6.11.5 Thoratec Recent Developments/Updates
6.12 Cleveland Heart
6.12.1 Cleveland Heart Corporation Information
6.12.2 Cleveland Heart Artificial Heart and Ventricular Assist Devices Description and Business Overview
6.12.3 Cleveland Heart Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Cleveland Heart Artificial Heart and Ventricular Assist Devices Product Portfolio
6.12.5 Cleveland Heart Recent Developments/Updates
6.13 CryoLife
6.13.1 CryoLife Corporation Information
6.13.2 CryoLife Artificial Heart and Ventricular Assist Devices Description and Business Overview
6.13.3 CryoLife Artificial Heart and Ventricular Assist Devices Sales, Revenue and Gross Margin (2019-2024)
6.13.4 CryoLife Artificial Heart and Ventricular Assist Devices Product Portfolio
6.13.5 CryoLife Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Heart and Ventricular Assist Devices Industry Chain Analysis
7.2 Artificial Heart and Ventricular Assist Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Heart and Ventricular Assist Devices Production Mode & Process
7.4 Artificial Heart and Ventricular Assist Devices Sales and 麻豆原创ing
7.4.1 Artificial Heart and Ventricular Assist Devices Sales Channels
7.4.2 Artificial Heart and Ventricular Assist Devices Distributors
7.5 Artificial Heart and Ventricular Assist Devices Customers
8 Artificial Heart and Ventricular Assist Devices 麻豆原创 Dynamics
8.1 Artificial Heart and Ventricular Assist Devices Industry Trends
8.2 Artificial Heart and Ventricular Assist Devices 麻豆原创 Drivers
8.3 Artificial Heart and Ventricular Assist Devices 麻豆原创 Challenges
8.4 Artificial Heart and Ventricular Assist Devices 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
SynCardia Systems
Medtronic PLC
Abbott Laboratories
BiVACOR
Berlin Heart
ABIOMED
LivaNova PLC
CARMAT
Jarvik Heart Inc
Chongqing Yongrenxin Medical
Thoratec
Cleveland Heart
CryoLife
听
听
*If Applicable.
